Literature DB >> 11180916

Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.

J Iwamoto1, T Takeda, S Ichimura.   

Abstract

The effect of the combined administration of vitamin D3 and vitamin K2 on bone mineral density (BMD) of the lumbar spine was examined in postmenopausal women with osteoporosis. Ninety-two osteoporotic women who were more than 5 years after menopause, aged 55-81 years, were randomly divided into four administration groups: vitamin D3 (1alpha hydroxyvitamin D3, 0.75 microg/day) (D group; n = 29), vitamin K2 (menatetrenone, 45 mg/day) (K group; n = 22), vitamin D3 plus vitamin K2 (DK group, n = 21), and calcium (calcium lactate, 2 g/day) (C group; n = 20). BMD of the lumbar spine (L2-L4) was measured by dual energy X-ray absorptiometry at 0, 1, and 2 years after the treatment started. There were no significant differences in age, body mass index, years since menopause, and initial BMD among the four groups. One-way analysis of variance (ANOVA) with repeated measurements showed a significant decrease in BMD in the C group (P < 0.001). Two-way ANOVA with repeated measurements showed a significant increase in BMD in the D and K groups compared with that in the C group (P < 0.05 and P < 0.001, respectively), and a significant increase in BMD in the DK group compared with that in the C, D, and K groups (P < 0.0001, P < 0.05 and P < 0.01, respectively). These findings indicate that combined administration of vitamin D3 and vitamin K2, compared with calcium administration, appears to be useful in increasing the BMD of the lumbar spine in postmenopausal women with osteoporosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11180916     DOI: 10.1007/s007760070003

Source DB:  PubMed          Journal:  J Orthop Sci        ISSN: 0949-2658            Impact factor:   1.601


  15 in total

1.  Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Authors:  Nina Emaus; Nguyen D Nguyen; Bjørg Almaas; Gro K Berntsen; Jacqueline R Center; Monika Christensen; Clara G Gjesdal; Anne S Grimsgaard; Tuan V Nguyen; Laila Salomonsen; John A Eisman; Vinjar M Fønnebø
Journal:  Eur J Nutr       Date:  2011-11-30       Impact factor: 5.614

Review 2.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

3.  Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.

Authors:  Z-B Huang; S-L Wan; Y-J Lu; L Ning; C Liu; S-W Fan
Journal:  Osteoporos Int       Date:  2014-12-17       Impact factor: 4.507

4.  Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.

Authors:  Ming Zhou; Shiliang Han; Wenpeng Zhang; Dan Wu
Journal:  J Bone Miner Metab       Date:  2022-06-16       Impact factor: 2.976

5.  Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Authors:  N Emaus; C G Gjesdal; B Almås; M Christensen; A S Grimsgaard; G K R Berntsen; L Salomonsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2009-11-25       Impact factor: 4.507

6.  A combination of low serum concentrations of vitamins K1 and D is associated with increased risk of hip fractures in elderly Norwegians: a NOREPOS study.

Authors:  T E Finnes; C M Lofthus; H E Meyer; A J Søgaard; G S Tell; E M Apalset; C Gjesdal; G Grimnes; B Schei; R Blomhoff; S O Samuelsen; K Holvik
Journal:  Osteoporos Int       Date:  2015-12-02       Impact factor: 4.507

Review 7.  Natural medicine delivery from biomedical devices to treat bone disorders: A review.

Authors:  Susmita Bose; Naboneeta Sarkar; Dishary Banerjee
Journal:  Acta Biomater       Date:  2021-02-28       Impact factor: 8.947

Review 8.  Vitamin K₂ therapy for postmenopausal osteoporosis.

Authors:  Jun Iwamoto
Journal:  Nutrients       Date:  2014-05-16       Impact factor: 5.717

Review 9.  Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men.

Authors:  Alison Avenell; Jenson C S Mak; Dianne O'Connell
Journal:  Cochrane Database Syst Rev       Date:  2014-04-14

10.  Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.

Authors:  Yan Jiang; Zhen-Lin Zhang; Zhong-Lan Zhang; Han-Min Zhu; Yi-Yong Wu; Qun Cheng; Feng-Li Wu; Xiao-Ping Xing; Jian-Li Liu; Wei Yu; Xun-Wu Meng
Journal:  Clin Interv Aging       Date:  2014-01-08       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.